<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR668/003/SRR6683813/SRR6683813.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR306/008/SRR3069538/SRR3069538.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR306/007/SRR3069537/SRR3069537.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Balk lab, Hem/Onc, BIDMC</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA307344</full_dataset_link><scientific_name>Homo sapiens</scientific_name><tag>xref:PubMed:27043282</tag><long_description>SOX9 is critical for prostate development and is implicated in prostate cancer, we used SOX9 ChIP-seq in combination with transcriptome profiling to identify genes and pathways it regulates in normal or neoplastic epithelium. Overall design: Chromatin was immunoprecipitated by SOX9 antibody in the TMPRSS2-ERG fusion positive prostate cancer cell line VCaP with high basal SOX9 expression and submitted for high throughput sequencing in parallel with input control.</long_description><repository>ENA</repository><description_synonyms>Dm DWnt3/5, ChIP-Chip, DWnt-5, DWnt-4, Chromatin Immuno-precipitation, Prostate Neoplasms, Dint-1, DmelCG4889, Neoplasms, AV220920, l(2)wg, CLIP-Seq, Assay for Transposase-Accessible Chromatin Using Sequencing, cmd1, DWnt-3/5, wnt-4, sox9, int-1, Dm-1, Dm-2, Dm-3, Chromatin Immunoprecipitation Sequencing-Chip, DmelCG1916, Prostatic Cancers, Dm Wg, Wnt-4, Cancer of Prostate, l(2)02657, Wnt-1, Wnt-3, Wnt-2, Prostate Cancers, Chromatin Immunoprecipitation Sequencing Chip, Chromatin Immuno precipitation Sequencing, CMD1, I, DmelCG6407, ChIP, Chromatin Immunoprecipitation Paired End Tag, Chromatin Immuno Precipitation Paired End Tag, Cross-Linking and Immunoprecipitation Followed by Deep Sequencing, dWnt, Wnt/Wg, DWnt5, WNT, Wnt, DWnt4, Wnt1, DWnt3, Sequencing, DWnt2, Wnt3, wnt4, Chromatin Immunoprecipitation Paired-End Tag, wnt3, wnt2, wnt1, Prostatic Neoplasm, Wnt3/5, 2010306G03Rik, DmelCG4698, Cancer of the Prostate, Dwnt5, sox9b, Dwnt4, wnt5, ATAC-Seq, Chromatin Immunoprecipitation Sequencing-Chips, Br, Prostatic, dWnt2, wnt, Sp, Cancer, hereditary prostate cancer, HITS-CLIP, High Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, cancer of the prostate, SRA1, l(2)rO727, Cross Linking and Immunoprecipitation Followed by Deep Sequencing, familial, ChIP Sequencing, ChIP-PET, wgl, ChIP-Exo, spd, clone 2.4, D-wnt-2, Prostatic Cancer, Neoplasm, mKIAA4243, NOS, cmpd1, High-Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, DWint-1, sra1, CG4889, activation, sox-9, DWnt3/5, fg, CMPD1, Drives, anon-WO03040301.228, anon-EST:Liang-2.4, WG, CG4698, Dwnt-2, Chromatin Immunoprecipitation, Dwnt-3, Chromatin Immuno-precipitation Sequencing, Cancers, ChIP Exonuclease, Dm DWnt2, cancer of prostate, ChIP-Seq, Dm DWnt4, Prostate Neoplasm, Assay for Transposase Accessible Chromatin Using Sequencing, CG1916, Dwnt-5, ChIA-PET., Chromatin Immuno-Precipitation Paired-End Tag, Wg, prostate cancer, PC, DWnt-3, DWnt-2, DWnt-1, Prostate Cancer, ChIP-Exonuclease, Gla, Prostate, CG6407</description_synonyms><name_synonyms>Human, Modern., human being, Man (Taxonomy), Homo sapiens, man, Man, human, Modern Man</name_synonyms></additional><is_claimable>false</is_claimable><name>Homo sapiens</name><description>SOX9 Drives WNT Pathway Activation in Prostate Cancer [ChIP-seq]</description><dates><last_updated>2025-09-24</last_updated><first_public>2017-04-19</first_public></dates><accession>PRJNA307344</accession><cross_references><GEO>GSE76451</GEO><taxon>9606</taxon><PubMed>27043282</PubMed></cross_references></HashMap>